Learn More
Apexbio Technology LLC Linifanib (ABT-869), 5mg. Cas: 796967-16-3 MFCD: MFCD11840918. VEGFR/PDGFR inhibitor

Supplier: Apexbio Technology LLC A29495
Linifanib (ABT-869) is an effective ATP-competitive tyrosine kinase inhibitor against the platelet-derived growth factor (PDGF) receptor and the vascular endothelial growth factor receptor (VEGFR) families, including constitutively active FMS-like receptor tyrosine kinase 3 (FLT3) [1][2]. Other sizes are available. Please inqury us for quote.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.